# Treatment Compliance in Children and Adolescents on ADHD Medication

> **NCT00540826** · — · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 518 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** stimulants (any approved ADHD medication)

## Key facts

- **NCT ID:** NCT00540826
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** 518 (ACTUAL)
- **Last updated:** 2009-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540826, "Treatment Compliance in Children and Adolescents on ADHD Medication". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00540826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*